Newsletter | November 21, 2022

11.21.22 -- Tips For Your Virtual Meetings With FDA

From The Editor
Featured Editorial
Industry Insights
Establishing A Remote Audit Process As A CDMO

Compliance audits are not immune to the effects of the pandemic. We have been required to adapt quickly to the changing environment to maintain high service levels while protecting employee and client safety.

Insights On Cell And Gene Therapy Manufacturing

Since the early 1990s, gene therapy has revolutionized medicine. In the coming years, it will continue to become more relevant in the treatment and cure of some of the most severe diseases and disorders.

Three Reasons Integrated CDMO Models Are Best

Some of pharma’s top brands developed their own responses to the demand for strategic outsourcing, creating a distinct class of contract development and manufacturing services suppliers.

Spotlight On Clinical Operations

The role of clinical operations plays an important part in the overall drug development process. Ian Nisbet, global vice president of clinical operations at Quotient Sciences, shares more about clinical operations.

Outsourced Pharma Live

Available On Demand! Throughout the year, chief editor Louis Garguilo brings together industry experts to discuss some of the biggest challenges being faced by both sponsors and CDMOs. Our archived videos can be accessed at any time by registered site users.